Nike release date

Nike GT Cut 3 Turbo Coconut Milk / Amarillo

Drop status

Released 1 year agoSee what's dropping next
Release date
August 1st, 2025
Retail price
$190.00

Be the first to vote

Release details

Nike GT Cut 3 Turbo Coconut Milk / Amarillo gives the Nike GT Cut 3 Turbo Coconut Milk / Amarillo another entry in the Nike archive, with release details collectors can compare against nearby drops. The style code is II3704-100, with a listed release date of August 1st, 2025 and a retail price of $190.00. SoleInsider tracks this Nike drop alongside related colorways so buyers can compare timing, pricing, and launch information.

The Nike GT Cut 3 Turbo in the Coconut Milk / Amarillo colorway exemplifies Nike s commitment to innovation and performance on the basketball court. This edition of the GT Cut series stands out with its creamy, off-white base aptly named Coconut Milk complemented by vibrant Amarillo accents that bring energy and flair to the shoe s appearance. Engineered for agility and explosive movement, the GT Cut 3 Turbo features an advanced cushioning system and a reinforced midsole for excellent response and impact protection. Lightweight mesh materials enhance breathability and lockdown, ensuring players stay comfortable and supported during high-intensity games.

Attention to detail is evident in the design elements throughout the shoe, such as the subtly textured overlays and the sharply contrasted Nike Swoosh. The outsole utilizes an updated traction pattern, granting superior grip for quick cuts and sudden stops on the court. Whether you re a serious athlete or a sneaker enthusiast, the Nike GT Cut 3 Turbo in Coconut Milk / Amarillo seamlessly merges function and style. Its bold color pairing and performance-first features make it a standout choice in Nike s contemporary basketball lineup, appealing to those who crave both visual appeal and advanced technology in their footwear.

Model
Nike GT Cut 3 Turbo Coconut Milk / Amarillo
Colorway
TBA
Style Code
II3704-100

Sponsored

Latest comments

No comments yet — be the first to weigh in